Med-X Inc. – Securities Investigation- Secondary Market Listing

Investigating Potential Claims involving Med-X Inc.

Are you concerned about your investment in Med-X Inc.? If so, the securities attorneys at The White Law Group may be able to help you.

Med-X, Inc. is a Nevada corporation formed in February 2014 in the cannabis industry.

According to the website, the Company has been in product development for a number of years, and is ready to bring various products to market in the cannabis pain management, agricultural and ancillary services industries through manufacturing partnerships such as Nature-Cide.

The company reportedly attempted to raise $15 million under Reg. A+ (crowdfunding) to “research and develop, through state of the art compound identification and extraction techniques,  market and sell medically beneficial supplements made from the oils synthesized from the cannabis plant.”

On September 16^th, 2016, the SEC issued a temporary halt to Med-X Reg. A+ offering. The company was required to file an annual report on Form 1-K for the fiscal year 2015. Med-X operates on a fiscal year ending December 31. As such, Med-X was required to file its annual report by April 30, 2016.

On September 16, Med-X had still not filed the annual report, so the SEC put a halt to the offering.

Is a Reg A+ investment suitable for you?

 Crowdfunding or Reg A+ of Title IV of the JOBS Act is a type of offering which allows private companies to raise up to $50 Million from the public. Like an IPO, Reg A+ allows companies to offer shares to the general public and not just accredited investors.

Similar to Regulation D private placements, Regulation A+ securities are illiquid. Investors looking to sell investments such as this, often have difficulty finding a buyer, and can suffer significant losses on the sale.

Currently, CFX Trading, a secondary market for private placements, is listing shares of Med-X Inc. for just $.59/share.

 Broker dealers are required to inform clients of the risks associated with investment recommendations. They must ensure that those recommendations are suitable for the investor in light of the investor’s age, risk tolerance, net worth, and investment experience. Firms that fail to do so may be held responsible for any losses.

If you are concerned about your investment in Med-X Inc. and would like to speak to a securities attorney about the potential to recover your investment losses, please call The White Law Group at 1-888-637-5510 for a free consultation.

The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Vero Beach, Florida. To learn more about The White Law Group visit www.whitesecuritieslaw.com.